Matches in SemOpenAlex for { <https://semopenalex.org/work/W2519820184> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2519820184 abstract "Background: Paediatric ependymomas are the second most common malignant brain tumours in children. Tumour recurrence, chemoresistance and invasion of surrounding critical structures are the hallmarks of ependymomas. These features are consistent with the cancer stem cell (CSC) hypothesis which states that tumours harbour a sub-population of stem-like cells which underlie therapeutic resistance. This study investigates the role of the radial glial stem cell marker BLBP, the multidrug transporter ABCB1, and the DNA repair enzyme MGMT in therapy failure in ependymomas with particular emphasis on the role of CSCs.Material and Methods: Database analyses were performed to assess the expression of the aforementioned markers in patients from 3 publicly available gene expression datasets. Furthermore, samples from 2 European paediatric ependymoma trial cohorts were screened for ABCB1, BLBP and MGMT expression by immunohistochemistry to elucidate their prognostic value. The expression of these markers was also determined in a panel of 5 ependymoma derived cell lines by QRT-PCR or western blotting analysis. Roles in chemoresistance (clonogenic & cytotoxicity assays) and tumour invasion (wound healing & 3D invasion assay) were then investigated.Results: Poor survival in the chemotherapy-led paediatric ependymoma CNS9204 trial was significantly associated with ABCB1 (P=0.007) and BLBP (P=0.03) expression whilst MGMT (P<0.001) and BLBP (P=0.002) expression predicted poor survival in the radiotherapy-led CNS9904 trial cohort. ABCB1 and BLBP expression was consistent with the CSC hypothesis whilst MGMT was expressed in both CSCs as well as the tumour bulk. Inhibition of ABCB1 and BLBP, with the phosphodiesterase-5 inhibitor vardenafil and PPAR-ϒ antagonist GW9662 respectively, potentiated response to chemotherapy and also inhibited the ability of ependymoma cell lines to migrate and invade. Finally, whilst each of the tested cell lines were resistant to the alkylating agent temozolomide, they were sensitive to the novel N3-propargyl analogue of temozolomide.Conclusion: ABCB1, BLBP and MGMT were not only markers of robust prognostic value but they also contributed functionally to the aggressive behaviour of ependymoma. Inhibition of ABCB1 and BLBP by vardenafil and GW9662 may represent effective approaches to overcome chemoresistance and invasion in ependymoma patients. The N3-propargyl analogue of temozolomide could also represent a novel treatment option for MGMT expressing ependymoma patients." @default.
- W2519820184 created "2016-09-23" @default.
- W2519820184 creator A5008298393 @default.
- W2519820184 date "2016-07-19" @default.
- W2519820184 modified "2023-09-24" @default.
- W2519820184 title "An investigation of druggable prognostic markers in paediatric ependymoma" @default.
- W2519820184 hasPublicationYear "2016" @default.
- W2519820184 type Work @default.
- W2519820184 sameAs 2519820184 @default.
- W2519820184 citedByCount "0" @default.
- W2519820184 crossrefType "dissertation" @default.
- W2519820184 hasAuthorship W2519820184A5008298393 @default.
- W2519820184 hasConcept C121608353 @default.
- W2519820184 hasConcept C126322002 @default.
- W2519820184 hasConcept C142724271 @default.
- W2519820184 hasConcept C143998085 @default.
- W2519820184 hasConcept C203014093 @default.
- W2519820184 hasConcept C204232928 @default.
- W2519820184 hasConcept C2781432949 @default.
- W2519820184 hasConcept C2908647359 @default.
- W2519820184 hasConcept C502942594 @default.
- W2519820184 hasConcept C55427017 @default.
- W2519820184 hasConcept C71924100 @default.
- W2519820184 hasConcept C86803240 @default.
- W2519820184 hasConcept C99454951 @default.
- W2519820184 hasConceptScore W2519820184C121608353 @default.
- W2519820184 hasConceptScore W2519820184C126322002 @default.
- W2519820184 hasConceptScore W2519820184C142724271 @default.
- W2519820184 hasConceptScore W2519820184C143998085 @default.
- W2519820184 hasConceptScore W2519820184C203014093 @default.
- W2519820184 hasConceptScore W2519820184C204232928 @default.
- W2519820184 hasConceptScore W2519820184C2781432949 @default.
- W2519820184 hasConceptScore W2519820184C2908647359 @default.
- W2519820184 hasConceptScore W2519820184C502942594 @default.
- W2519820184 hasConceptScore W2519820184C55427017 @default.
- W2519820184 hasConceptScore W2519820184C71924100 @default.
- W2519820184 hasConceptScore W2519820184C86803240 @default.
- W2519820184 hasConceptScore W2519820184C99454951 @default.
- W2519820184 hasLocation W25198201841 @default.
- W2519820184 hasOpenAccess W2519820184 @default.
- W2519820184 hasPrimaryLocation W25198201841 @default.
- W2519820184 hasRelatedWork W104508307 @default.
- W2519820184 hasRelatedWork W2045476312 @default.
- W2519820184 hasRelatedWork W2056983219 @default.
- W2519820184 hasRelatedWork W2073620279 @default.
- W2519820184 hasRelatedWork W2082727723 @default.
- W2519820184 hasRelatedWork W2089653838 @default.
- W2519820184 hasRelatedWork W2091448834 @default.
- W2519820184 hasRelatedWork W2145685767 @default.
- W2519820184 hasRelatedWork W2148364504 @default.
- W2519820184 hasRelatedWork W236598522 @default.
- W2519820184 hasRelatedWork W2417340969 @default.
- W2519820184 hasRelatedWork W2510930657 @default.
- W2519820184 hasRelatedWork W2564895620 @default.
- W2519820184 hasRelatedWork W2767834262 @default.
- W2519820184 hasRelatedWork W2810027651 @default.
- W2519820184 hasRelatedWork W2964883816 @default.
- W2519820184 hasRelatedWork W2977695319 @default.
- W2519820184 hasRelatedWork W2979766702 @default.
- W2519820184 hasRelatedWork W3190896923 @default.
- W2519820184 hasRelatedWork W959831581 @default.
- W2519820184 isParatext "false" @default.
- W2519820184 isRetracted "false" @default.
- W2519820184 magId "2519820184" @default.
- W2519820184 workType "dissertation" @default.